Medical Doctor, Medical Governance Research Institute
Akihiko Ozaki graduated from medical school at the University of Tokyo in 2010. While working as a breast cancer surgeon, he has been researching questionable industry payments in Japan's medical world. Namely, he pointed out a series of financial issues in the CREATE-X trial, which was performed in Korea and Japan, and his research was published in the New England Journal of Medicine, one of the most prestigious medical journals in the world. He currently aims to comprehensively investigate financial relationships between pharmaceutical companies and physicians in Japan. Relevant academic publications: Ozaki A (2018). Conflict of interest and the CREATE-X trial in the New England Journal of Medicine. Science and Engineering Ethics. DOI: 10.1007/s11948-017-9966-3. Ozaki A, Takita M, Tanimoto T (2018). A call for improved transparency in financial aspects of clinical trials: a case study of the CREATE-X trial in the New England Journal of Medicine. Investigational New Drugs. DOI: https://doi.org/10.1007/s10637-018-0577-x
Akihiko is speaking at
From infectious disease epidemics to the pharmaceutical industry, from the quality of health care to fraud and fake drugs, covering medicine and health is a rich but challenging topic for investigative journalists. One needs a knowledge of science with an enterprising approach to sources and data. Here are three varied approaches that offer a gold mine of ideas on topics like tracking response to disease outbreaks, drug safety, and industry payoffs to doctors.
Add to my calendar
Create your personal schedule through the official app, Whova!Get Started